Review article

implementation of a diet low in FODMAPs for patients with irritable bowel syndrome—directions for future research

Hannah Mitchell, Judi Porter, Peter R. Gibson, Jacqueline Barrett, Mayur Garg

Research output: Contribution to journalReview ArticleResearchpeer-review

9 Citations (Scopus)

Abstract

Background: Despite the efficacy of a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) for patients with irritable bowel syndrome, many questions remain unanswered with respect to its clinical implementation. Aim: To review literature to identify, synthesise, and provide direction for future research in the implementation and evaluation of the low FODMAP diet. Methods: Bibliographical searches were performed in Ovid Medline, CINAHL, Scopus and PubMed from database commencement until September 2018, with search terms focused on the population (irritable bowel syndrome) and intervention of interest (FODMAP). Results: Predictors of response to a low FODMAP diet remain under investigation, with preliminary data supporting faecal microbiota or faecal volatile organic compound profiling. Training of clinicians, and standards for the education of patients about the phases of a low FODMAP diet, as well as the role of Apps, require formal evaluation. There are limited data on the longer term efficacy and safety of the low FODMAP diet with respect to sustained symptom control, effect on quality of life and healthcare utilisation, nutritional adequacy, precipitation of disordered eating behaviours, effects on faecal microbiota and metabolomic markers, and subsequent translation to clinical effects. Conclusions: Many gaps in implementation of the low FODMAP diet in clinical practice, as well as long-term safety and efficacy, remain for further investigation.

Original languageEnglish
Pages (from-to)124-139
Number of pages16
JournalAlimentary Pharmacology and Therapeutics
Volume49
Issue number2
DOIs
Publication statusPublished - 1 Jan 2019

Cite this

@article{8c13e706926b4145a60f3e8ff5596f8f,
title = "Review article: implementation of a diet low in FODMAPs for patients with irritable bowel syndrome—directions for future research",
abstract = "Background: Despite the efficacy of a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) for patients with irritable bowel syndrome, many questions remain unanswered with respect to its clinical implementation. Aim: To review literature to identify, synthesise, and provide direction for future research in the implementation and evaluation of the low FODMAP diet. Methods: Bibliographical searches were performed in Ovid Medline, CINAHL, Scopus and PubMed from database commencement until September 2018, with search terms focused on the population (irritable bowel syndrome) and intervention of interest (FODMAP). Results: Predictors of response to a low FODMAP diet remain under investigation, with preliminary data supporting faecal microbiota or faecal volatile organic compound profiling. Training of clinicians, and standards for the education of patients about the phases of a low FODMAP diet, as well as the role of Apps, require formal evaluation. There are limited data on the longer term efficacy and safety of the low FODMAP diet with respect to sustained symptom control, effect on quality of life and healthcare utilisation, nutritional adequacy, precipitation of disordered eating behaviours, effects on faecal microbiota and metabolomic markers, and subsequent translation to clinical effects. Conclusions: Many gaps in implementation of the low FODMAP diet in clinical practice, as well as long-term safety and efficacy, remain for further investigation.",
author = "Hannah Mitchell and Judi Porter and Gibson, {Peter R.} and Jacqueline Barrett and Mayur Garg",
year = "2019",
month = "1",
day = "1",
doi = "10.1111/apt.15079",
language = "English",
volume = "49",
pages = "124--139",
journal = "Alimentary Pharmacology and Therapeutics",
issn = "0269-2813",
publisher = "Wiley-Blackwell",
number = "2",

}

Review article : implementation of a diet low in FODMAPs for patients with irritable bowel syndrome—directions for future research. / Mitchell, Hannah; Porter, Judi; Gibson, Peter R.; Barrett, Jacqueline; Garg, Mayur.

In: Alimentary Pharmacology and Therapeutics, Vol. 49, No. 2, 01.01.2019, p. 124-139.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Review article

T2 - implementation of a diet low in FODMAPs for patients with irritable bowel syndrome—directions for future research

AU - Mitchell, Hannah

AU - Porter, Judi

AU - Gibson, Peter R.

AU - Barrett, Jacqueline

AU - Garg, Mayur

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Background: Despite the efficacy of a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) for patients with irritable bowel syndrome, many questions remain unanswered with respect to its clinical implementation. Aim: To review literature to identify, synthesise, and provide direction for future research in the implementation and evaluation of the low FODMAP diet. Methods: Bibliographical searches were performed in Ovid Medline, CINAHL, Scopus and PubMed from database commencement until September 2018, with search terms focused on the population (irritable bowel syndrome) and intervention of interest (FODMAP). Results: Predictors of response to a low FODMAP diet remain under investigation, with preliminary data supporting faecal microbiota or faecal volatile organic compound profiling. Training of clinicians, and standards for the education of patients about the phases of a low FODMAP diet, as well as the role of Apps, require formal evaluation. There are limited data on the longer term efficacy and safety of the low FODMAP diet with respect to sustained symptom control, effect on quality of life and healthcare utilisation, nutritional adequacy, precipitation of disordered eating behaviours, effects on faecal microbiota and metabolomic markers, and subsequent translation to clinical effects. Conclusions: Many gaps in implementation of the low FODMAP diet in clinical practice, as well as long-term safety and efficacy, remain for further investigation.

AB - Background: Despite the efficacy of a diet low in fermentable oligosaccharides, disaccharides, monosaccharides, and polyols (FODMAP) for patients with irritable bowel syndrome, many questions remain unanswered with respect to its clinical implementation. Aim: To review literature to identify, synthesise, and provide direction for future research in the implementation and evaluation of the low FODMAP diet. Methods: Bibliographical searches were performed in Ovid Medline, CINAHL, Scopus and PubMed from database commencement until September 2018, with search terms focused on the population (irritable bowel syndrome) and intervention of interest (FODMAP). Results: Predictors of response to a low FODMAP diet remain under investigation, with preliminary data supporting faecal microbiota or faecal volatile organic compound profiling. Training of clinicians, and standards for the education of patients about the phases of a low FODMAP diet, as well as the role of Apps, require formal evaluation. There are limited data on the longer term efficacy and safety of the low FODMAP diet with respect to sustained symptom control, effect on quality of life and healthcare utilisation, nutritional adequacy, precipitation of disordered eating behaviours, effects on faecal microbiota and metabolomic markers, and subsequent translation to clinical effects. Conclusions: Many gaps in implementation of the low FODMAP diet in clinical practice, as well as long-term safety and efficacy, remain for further investigation.

UR - http://www.scopus.com/inward/record.url?scp=85059223554&partnerID=8YFLogxK

U2 - 10.1111/apt.15079

DO - 10.1111/apt.15079

M3 - Review Article

VL - 49

SP - 124

EP - 139

JO - Alimentary Pharmacology and Therapeutics

JF - Alimentary Pharmacology and Therapeutics

SN - 0269-2813

IS - 2

ER -